JPMorgan Exits Substantial Shareholder Position in Cochlear Ltd
JPMorgan Chase & Co. has exited its substantial shareholder position in Cochlear Ltd as of September 2, 2026.
The move follows a series of transactions involving ordinary shares and securities lending arrangements that have resulted in a reduction of JPMorgan's overall stake in the company.
Cochlear is an Australian medical device company specializing in implantable hearing solutions, including cochlear implants and related technologies for people with severe to profound hearing loss.
The exit of JPMorgan as a substantial holder may influence market perception of Cochlear's ownership structure and could have implications for liquidity and future institutional participation.